Found: 8
Select item for more details and to access through your institution.
Clinical features of immune-mediated hepatotoxicity induced by immune checkpoint inhibitors in patients with cancers.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 6, p. 1747, doi. 10.1007/s00432-020-03448-8
- By:
- Publication type:
- Article
GPR43 Suppresses Intestinal Tumor Growth by Modification of the Mammalian Target of Rapamycin Complex 1 Activity in ApcMin/+ Mice.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 8, p. 815, doi. 10.3390/diagnostics14080815
- By:
- Publication type:
- Article
Clinical Significance and Remaining Issues of Anti-HBc Antibody and HBV Core-Related Antigen.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 7, p. 728, doi. 10.3390/diagnostics14070728
- By:
- Publication type:
- Article
Correction: LAT1 expression influences Paneth cell number and tumor development in Apc<sup>Min/+</sup> mice.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
LAT1 expression influences Paneth cell number and tumor development in Apc<sup>Min/+</sup> mice.
- Published in:
- Journal of Gastroenterology, 2023, v. 58, n. 5, p. 444, doi. 10.1007/s00535-023-01960-5
- By:
- Publication type:
- Article
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma.
- Published in:
- JGH Open, 2023, v. 7, n. 7, p. 476, doi. 10.1002/jgh3.12932
- By:
- Publication type:
- Article
Feasibility of the lidocaine injection method during esophageal endoscopic submucosal dissection.
- Published in:
- JGH Open, 2020, v. 4, n. 2, p. 251, doi. 10.1002/jgh3.12257
- By:
- Publication type:
- Article